In addition, risk prediction of the complete HOXAhi- and HOXAlo-patient cohort was dependent on 3 key genes, namely FLT3, TACC2 and IRX2. High expression of non-mutated FLT3 is a typical feature in t(4;11) leukemia. This evidence concerns the gene FLT3 and leukemia.